Scarica l'app Stockscreener
8.85
4.36%
0.37
Dopo l'orario di chiusura:
8.89
0.04
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
Why Novavax (NVAX) Is Up 26.0% After Surging Year-to-Date Profits Despite Lower Quarterly Results - simplywall.st
CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency - Benzinga
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction - Benzinga
Biotech sector slips amid reported return of ousted FDA official (SRPT:NASDAQ) - Seeking Alpha
Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk - Benzinga
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View - MSN
Novavax Stock Surges 24% Amid Milestone Payment and Strategic Gains - AInvest
Novavax slips as Citi launches with Sell rating on pipeline concerns - MSN
Novavax’s Q2 Financial Success: A Game Changer? - StocksToTrade
Novavax, Inc. (NASDAQ:NVAX) Q2 2025 Earnings Call Transcript - Insider Monkey
Novavax Reports Strong Earnings Amid Strategic Shifts - TipRanks
Decoding Novavax Inc (NVAX): A Strategic SWOT Insight - GuruFocus
Novavax: Q2 Earnings Snapshot - Connecticut Post
Novavax Q2 2025 Earnings Call Transcript - MarketBeat
Novavax (NVAX) Profit Jumps on Milestone - The Globe and Mail
Novavax raises 2025 revenue target to $1.05B with milestone payments and streamlined expenses as Sanofi partnership progresses - MSN
Novavax higher after Q2 beat as partnerships brighten outlook - MSN
Novavax (NVAX) Reports Q2 Progress and Key Partnership Developme - GuruFocus
Transcript : Novavax, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Novavax expects post-marketing Covid study to cost up to $90M - Endpoints News
Novavax stock surges as HHS pulls mRNA vaccine funding, opening doors for alternative technologies - The Business Journals
Novavax outlook 2025 adjusted revenue $1 bln to $1.05 bln versus IBES estimate $1.02 bln - MarketScreener
Novavax CFO Says Sanofi To Cover Majority Of Future Nuvaxovid Study Costs, Retail Urges Partnership Diversification - Investing.com India
Novavax banks on vaccine supply partnerships to boost 2025 revenue - Reuters
Novavax Shares Rise Following Avian Flu Vaccine Success - StocksToTrade
Novavax’s Vaccine Breakthrough Signals Optimism Amid Changing Market Dynamics - timothysykes.com
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales - Yahoo Finance
Novavax (NVAX) Boosts 2025 Revenue Outlook Amid Strategic Collab - GuruFocus
Earnings call transcript: Novavax Q2 2025 reports unexpected profit, stock surges - Investing.com Canada
Novavax Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Can Novavax’s Innovation Fuel a Stock Rebound? - StocksToTrade
Novavax Q2 2025 slides: Milestone revenue drives profit amid strategic shift - Investing.com Australia
Novavax Q2 Earnings, Revenue Fall; Full-Year Adjusted Revenue Outlook Raised - MarketScreener
Novavax (NVAX) Raises Revenue Forecast Amid Strong Vaccine Partn - GuruFocus
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Novavax (NVAX) Surpasses Earnings Expectations with Revenue Boos - GuruFocus
Earnings snapshot: Novavax tops Q2 estimates; raises full-year outlook - MSN
Novavax stock higher on Q2 beat, guidance (NVAX:NASDAQ) - Seeking Alpha
Novavax raises annual revenue forecast on vaccine supply partnerships - Reuters
Novavax lifts 2025 revenue outlook after FDA milestone payment By Investing.com - Investing.com Canada
Novavax earnings beat by $0.68, revenue topped estimates - Investing.com Canada
Novavax Inc (NVAX) Q2 2025 Earnings: EPS of $0.62 Beats Estimate, Revenue Surges to $239 Million - GuruFocus
Novavax Reports Second Quarter 2025 Financial Results and Operat - GuruFocus
Novavax's Strategic Transformation and Revenue Catalysts in 2025: A High-Conviction Play in Vaccine Innovation - AInvest
Novavax beats quarterly revenue estimates on milestone payment - Yahoo Finance
Earnings Flash (NVAX) Novavax, Inc. Reports Q2 Revenue $239.2M, vs. FactSet Est of $152.6M - MarketScreener
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights - TradingView
Earnings Flash (NVAX) Novavax Posts Q2 Revenue $239.2M, vs. FactSet Est of $152.6M - MarketScreener
NOVAVAX INC SEC 10-Q Report - TradingView
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):